Issue 7, 2025

Metal-coordination-driven self-assembly of DNA nanohybrids for robust intracellular anti-tuberculosis therapy

Abstract

Due to traditional antibiotics’ limitations in treating tuberculosis (TB), this study presents a DNA-based nanoarchitecture that combines isoniazid (INH) and CpG via Fe2+-assisted coordination-driven self-assembly. This strategy enhances antibiotic efficacy and activates the host immune response, offering a potential avenue for improved TB treatment.

Graphical abstract: Metal-coordination-driven self-assembly of DNA nanohybrids for robust intracellular anti-tuberculosis therapy

Supplementary files

Article information

Article type
Communication
Submitted
11 Nov 2024
Accepted
14 Jan 2025
First published
20 Jan 2025

New J. Chem., 2025,49, 2651-2655

Metal-coordination-driven self-assembly of DNA nanohybrids for robust intracellular anti-tuberculosis therapy

K. Zhang, H. Sun, X. Gao, T. Liang, X. Gao, H. Song, C. Guan, Z. Sun and J. Zhang, New J. Chem., 2025, 49, 2651 DOI: 10.1039/D4NJ04870A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements